BREAKING
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 1 day ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 1 day ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 1 day ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 1 day ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago
ADVERTISEMENT
Market News

Gevo (NASDAQ: GEVO): Q3 2019 Earnings Snapshot

— Gevo Inc. (NASDAQ: GEVO) reported a third-quarter 2019 adjusted loss of $0.66 per share versus a loss of $0.55 per share expected. — Total revenues fell by 29% to $6.11 million versus $4.77 million expected. The results were hurt by lower ethanol sales. — Revenues derived at the Luverne Facility related to ethanol sales […]

$GEVO November 12, 2019 1 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results
NYSE
$GEVO · Earnings

— Gevo Inc. (NASDAQ: GEVO) reported a third-quarter 2019 adjusted loss of $0.66 per share versus a loss of $0.55 per share expected. — Total revenues fell by 29% to $6.11 million versus $4.77 million expected. The results were hurt by lower ethanol sales. — Revenues derived at the Luverne Facility related to ethanol sales […]

· November 12, 2019

— Gevo Inc. (NASDAQ: GEVO) reported a third-quarter 2019 adjusted loss of $0.66 per share versus a loss of $0.55 per share expected.

— Total revenues fell by 29% to $6.11 million versus $4.77 million expected. The results were hurt by lower ethanol sales.

Earnings Update by AlphaStreet

— Revenues derived at the Luverne Facility related to ethanol sales and related products fell by 31% due to reduced production of ethanol and distiller grains as a result of unfavorable commodity environment.

— Hydrocarbon revenues increased by 9% helped by higher production volumes at the South Hampton Resources Inc. facility in Silsbee, Texas.

— Research and development expenses declined by 4% due primarily to a decrease in costs associated with its South Hampton Facility partially offset by an increase in personnel and consultant expenses.

ADVERTISEMENT

— Gevo believes it can become profitable, or close to it, as a company by the end of 2021 if Gevo can successfully improve the carbon footprint of its Luverne Facility.

— Gevo expects one or more of its renewable natural gas projects that are under development to come on-line by the end of 2020 or early 2021, adding to its EBITDA in 2021.

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

ADVERTISEMENT